Search research articles
Contact Us
Filters
Showing results (91-100 of 183) with videos related to
Page
of 19
Sort By:
Blood Advances
|
August 16, 2022
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression
Pau Abrisqueta, Daniel Medina, Guillermo Villacampa, et al.
British Journal of Haematology
|
August 16, 2005
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study
Mark Ringhoffer, Norbert Blumstein, Bernd Neumaier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 4, 2006
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation
Thorsten Zenz, Richard F Schlenk, Gerhard Glatting, et al.
Blood
|
February 26, 2025
Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trial
Adalgisa Condoluci, Ilaria Romano, Daniel Dietrich, et al.
Nature Communications
|
June 11, 2021
Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia
Veronika Ecker, Martina Stumpf, Lisa Brandmeier, et al.
Haematologica
|
January 13, 2018
Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin
Claudia Dürr, Bola S Hanna, Angela Schulz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial
Andreas Engert, Andreas Josting, Heinz Haverkamp, et al.
Blood
|
January 9, 2017
HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling
Roland Walter, Kuan-Ting Pan, Carmen Doebele, et al.
Haematologica
|
September 9, 2010
Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis
René Scholtysik, Markus Kreuz, Wolfram Klapper, et al.
Blood
|
May 28, 2020
Identification of 2 DNA methylation subtypes of Waldenström macroglobulinemia with plasma and memory B-cell features
Damien Roos-Weil, Brian Giacopelli, Marine Armand, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 183) with videos related to
Sort By:
Page
of 19
Blood Advances
|
August 16, 2022
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression
Pau Abrisqueta, Daniel Medina, Guillermo Villacampa, et al.
British Journal of Haematology
|
August 16, 2005
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study
Mark Ringhoffer, Norbert Blumstein, Bernd Neumaier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 4, 2006
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation
Thorsten Zenz, Richard F Schlenk, Gerhard Glatting, et al.
Blood
|
February 26, 2025
Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trial
Adalgisa Condoluci, Ilaria Romano, Daniel Dietrich, et al.
Nature Communications
|
June 11, 2021
Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia
Veronika Ecker, Martina Stumpf, Lisa Brandmeier, et al.
Haematologica
|
January 13, 2018
Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin
Claudia Dürr, Bola S Hanna, Angela Schulz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial
Andreas Engert, Andreas Josting, Heinz Haverkamp, et al.
Blood
|
January 9, 2017
HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling
Roland Walter, Kuan-Ting Pan, Carmen Doebele, et al.
Haematologica
|
September 9, 2010
Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis
René Scholtysik, Markus Kreuz, Wolfram Klapper, et al.
Blood
|
May 28, 2020
Identification of 2 DNA methylation subtypes of Waldenström macroglobulinemia with plasma and memory B-cell features
Damien Roos-Weil, Brian Giacopelli, Marine Armand, et al.
Page
of 19